2m 2m 2m 2m 2m 2m 2m
ATRIUM THERAP (RNA)
NASDAQ
$11.30-$0.05 (-0.47%)
Price as of Aug 03, 2026 4:31 AM EDT- $194.1MMarket Cap
- -68.40%1-Year Change
- BiotechnologyIndustry
ATRIUM THERAP (RNA)
$11.30-$0.05 (-0.47%)
RNA | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $11.35 | ||
Change | -$0.11 (-0.96%) | ||
Open | $11.44 | ||
High | $11.54 | ||
Low | $11.20 | ||
Previous Close | $11.46 | ||
Volume | 116,293 | ||
30-Day Average Volume | 161,124 | ||
1-Week Change | -1.22% | ||
1-Month Change | -15.61% | ||
1-Year Change | -68.40% | ||
3-Year Change | 19.35% | ||
5-Year Change | -41.22% | ||
Fundamentals | |||
Shares Outstanding | 17.1M | ||
Total Assets | $292.4M | ||
Market Cap | $194.1M | ||
Enterprise Value | -$73.7M | ||
Period: QTR TTM FY | |||
Revenue | $19.6M | ||
Net Income | -$16.6M | ||
Free Cash Flow | -$33.2M | ||
EBIT | -$16.6M | ||
EBITDA | -$16.5M | ||
Net Working Capital | N/A | ||
EPS | -$0.97 | ||
Enterprise Value/EBITDA | 4 | ||
Enterprise Value/Revenue | -4 | ||
P/B | 1 | ||
P/E | -12 | ||
PEG | N/A | ||
Price/Free Cash Flow | -6 | ||
Price/Operating Cash Flow | -6 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||